AccuStem Sciences, Inc. (ACUT)
OTCMKTS · Delayed Price · Currency is USD
0.1719
+0.0159 (10.19%)
At close: Jul 6, 2026
AccuStem Sciences Market Cap
AccuStem Sciences has a market cap or net worth of $2.51 million as of July 6, 2026. Its market cap has decreased by -50.89% in one year.
Market Cap
2.51M
Enterprise Value
2.50M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.17
Market Cap Chart
Since March 2, 2022, AccuStem Sciences's market cap has decreased from 20.42M to 2.51M, a decrease of -87.72%. That is a compound annual growth rate of -38.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 2.76M | -78.87% |
| Dec 31, 2025 | 13.07M | 157.22% |
| Dec 31, 2024 | 5.08M | -28.40% |
| Dec 29, 2023 | 7.10M | -53.62% |
| Dec 30, 2022 | 15.31M | -25.04% |
| Mar 2, 2022 | 20.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CASI Pharmaceuticals | 3.02M |
| Bioxytran | 2.85M |
| Vaccinex | 2.73M |
| Iterum Therapeutics | 2.64M |
| Institute of Biomedical Research | 2.58M |
| Hepion Pharmaceuticals | 2.44M |
| Bio-Path Holdings | 2.36M |
| VitaSpring Biomedical | 2.30M |